PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanolic fruit and leaf extracts significantly inhibited the secretion of multiple pro-inflammatory cytokines and chemokines in LPS-stimulated macrophages [PMID:38581641]
Fruit and leaf extracts demonstrate strong antibacterial activity against various pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and Shewanella spp. [PMID:31597166, PMID:30497593]
Juice reactivates RB functions to inhibit the growth of human colon cancer LIM1215 cells [PMID:37743524]; leaf-conjugated gold nanoparticles inhibited breast cancer (MCF-7) and cervical carcinoma cells [PMID:41465768]
Aqueous ellagic acid enriched extract significantly reduced ROS production in Caco-2 and KERTr cell lines [PMID:31343981]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36985798 (2023) — Bioactive Properties of Kakadu Plum-Blended Products. · Molecules (Basel, Switzerland)
- 2.PMID: 39766223 (2024) — Green Synthesis of Terminalia ferdinandiana Exell-Mediated Silver Nanoparticles and Evaluation of Antibacterial Performance. · Biomolecules
- 3.PMID: 29649154 (2018) — Chemical and Nutritional Composition of Terminalia ferdinandiana (Kakadu Plum) Kernels: A Novel Nutrition Source. · Foods (Basel, Switzerland)
- 4.PMID: 41391874 (2025) — Terminalagin, a New Ellagitannin from Kakadu Plum (Terminalia ferdinandiana). · Chemical & pharmaceutical bulletin
- 5.PMID: 28460910 (2016) — Organic acids in Kakadu plum (Terminalia ferdinandiana): The good (ellagic), the bad (oxalic) and the uncertain (ascorbic).